Stability of Biopharmaceuticals 2023
MIbio 2023
The 11th MIBio conference will occur at Howard Theatre, Downing College, Cambridge, on 18th October 2023.
MIBio engages leading experts from industry and academia in a discussion on how the latest molecular interaction-based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly, and safer therapeutic products.
The 2023 meeting will focus on a number of aspects of cutting edge biopharmaceutical product development, including patient-centric dosage forms, both from the formulation and from the device point of view. In addition, for the first time in the MIBio series, recent advances and future outlook in oral delivery will be discussed. Last but not least, presentations and discussions will cover development of novel dosage forms and the use of artificial intelligence to achieve better products.
There will be around 100 delegates from biopharma industry, academia and technology suppliers to create a stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation of formulation technologies.
We look forward to seeing you at MIBio 2023!
The Programme
08:00 Registration opens
09:00 Opening remarks
09:15 Drug Delivery Dynamics & Future outlook: a Strategic Perspective - Didier Pertuy | Sanofi
09:45 Human Factors Considerations for Formulation Development - Katie Cornish | AstraZeneca
10:15 Speed Networking
11:15 Oral biopharmaceutical delivery: Not directly replacing a shot with a pill - Randy Mrsny | University of Bath
11:45 Advanced drug delivery strategies for oral administration of peptides and proteins - Stephen Buckley | Novo Nordisk
12:15 Lunch Break, Exhibition and Posters
13:30 Introduction to the afternoon session
13:45 Discussion panel
14:45 Exhibitors highlights
15:30 Coffee break, Exhibition and Posters
16:00 Oral biopharmaceutical delivery: Not directly replacing a shot with a pill - Randy Mrsny | University of Bath
16:30 Title to be announced
17:00 Concluding remarks
17:10 Conference ends